LLY

Eli Lilly & Co
D

LLY

Arincen80/100B

Eli Lilly & Co total debt 1985–2026

Eli Lilly & Co's total debt was 49.50B USD on 30 September 2026, up 16.5% on a year before. At the end of fiscal year 2025 it was 42.50B USD.

Last updated 10 Nov 2026 · Next report 3 Feb 2027

Total debt

Growth

Fiscal yearPeriod endingTotal debtGrowthCash and short-term investmentsNet cashDebt to equity
Latest quarter30 Sept 202649.50B+16.46%4.89B-44.62B1.23
FY202531 Dec 202542.50B+26.33%7.37B-35.13B1.60
FY202431 Dec 202433.64B+33.37%3.42B-30.22B2.37
FY202331 Dec 202325.23B+55.34%2.93B-22.30B2.34
FY202231 Dec 202216.24B-3.83%2.21B-14.03B1.52
FY202131 Dec 202116.88B+1.74%3.91B-12.98B1.88
FY202031 Dec 202016.60B+5.01%3.68B-12.91B2.94
FY201931 Dec 201915.80B+53.46%2.44B-13.37B6.06
FY201831 Dec 201810.30B-24.54%7.41B-2.89B1.05
FY201731 Dec 201713.65B+32.43%8.03B-5.61B1.18
FY201631 Dec 201610.31B+29.16%6.04B-4.27B0.74
FY201531 Dec 20157.98B-0.97%4.45B-3.53B0.55
FY201431 Dec 20148.06B+54.55%4.83B-3.23B0.52
FY201331 Dec 20135.21B-5.76%5.40B184.40M0.30
FY201231 Dec 20125.53B-20.83%5.68B153.00M0.37
FY201131 Dec 20116.99B+0.87%6.90B-89.90M0.52
FY201031 Dec 20106.93B+3.97%6.73B-199.50M0.56
FY200931 Dec 20096.66B-36.32%4.50B-2.16B0.70
FY200831 Dec 200810.46B+108.94%5.93B-4.54B1.55
FY200731 Dec 20075.01B+34.83%4.83B-176.00M0.37
FY200631 Dec 20063.71B-42.85%3.89B177.20M0.34
FY200531 Dec 20056.50B-0.22%5.04B-1.46B0.60
FY200431 Dec 20046.51B+33.34%7.46B951.90M0.60
FY200331 Dec 20034.88B-0.39%3.71B-1.17B0.50
FY200231 Dec 20024.90B+43.45%3.65B-1.25B0.59
FY200131 Dec 20013.42B+21.31%3.73B312.60M0.48
FY200031 Dec 20002.82B-7.71%4.62B1.80B0.47
FY199931 Dec 19993.05B+29.00%3.84B782.60M0.61
FY199831 Dec 19982.37B-7.31%1.50B-871.20M0.53
FY199731 Dec 19972.55B-31.53%1.95B-606.20M0.55
FY199631 Dec 19963.73B-17.16%813.70M-2.92B0.61
FY199531 Dec 19954.50B-7.19%999.50M-3.50B0.83
FY199431 Dec 19944.85B+256.63%536.90M-4.31B0.91
FY199331 Dec 19931.36B+15.89%539.60M-820.40M0.30
FY199231 Dec 19921.17B+8.09%432.40M-741.10M0.24
FY199131 Dec 19911.09B-28.41%479.20M-606.50M0.22
FY199031 Dec 19901.52B+275.84%350.20M-1.17B0.44
FY198931 Dec 1989403.50M-21.60%323.00M-80.50M0.11
FY198831 Dec 1988514.70M-14.77%761.50M246.80M0.16
FY198731 Dec 1987603.90M-3.56%1.03B427.00M0.20
FY198631 Dec 1986626.20M+162.45%486.00M-140.20M0.23
FY198531 Dec 1985238.60M—406.10M167.50M0.10

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Total debt counts commercial paper, term debt and lease liabilities.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet

Common questions about Eli Lilly & Co's debt

Source: Financial Modeling Prep